<DOC>
	<DOCNO>NCT01416844</DOCNO>
	<brief_summary>In study , anti-OX40 give patient melanoma find immune system respond treatment anti-OX40 . It hop treatment cause immune response melanoma result tumor regression , know time . Anti-OX40 large protein help immune cell fight bacteria , virus cancer cell .</brief_summary>
	<brief_title>Study Immune Responses Patients With Metastatic Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>1 . Patients measurable evaluable unresectable , stage IV metastatic melanoma . Either histologic cytologic diagnosis acceptable . 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 ( Appendix A . ) 3 . Age 18 year . 4 . Laboratory value ( perform within 28 day prior enrollment ) follow : WBC â‰¥2000/microliter Absolute lymphocyte count &gt; 300/mm3 Serum creatinine &lt; 1.5 X upper limit laboratory normal Hgb &gt; 8g/dl ( patient may transfuse reach level ) Hct &gt; 24 % Platelets &gt; 100,000 cells/mm3 Total bilirubin &lt; 1.5 X upper limit laboratory normal , unless due Gilbert 's disease AST ( SGOT ) /ALT ( SGPT ) &lt; 2.5 X upper limit laboratory normal Alkaline phosphatase &lt; 2.5 X upper limit laboratory normal HIV Negative Hepatitis B surface antigen Negative Hepatitis C antibody Negative 5 . Women childbearing potential must negative pregnancy test must avoid become pregnant treatment . Men must avoid father child treatment . This exclusion require due unknown toxicity antiOX40 may form fetus , spermatogenesis nursing child . Also , pregnancy may impair immune function may limit treatment efficacy . 6 . Ability give inform consent comply protocol . Patients history psychiatric illness must judge able understand fully investigational nature study risk associate therapy . 7 . No active bleeding . 8 . No clinical coagulopathy ( INR &lt; 1.5 , PT &lt; 16 second , PTT &lt; 38 second ) . 9 . Anticipated lifespan great 12 week . 10 . Failed least one prior medical therapy metastatic melanoma . 1 . Active infection . 2 . History active autoimmune disease . 3 . Prior mouse monoclonal antibody treatment . 4 . Pregnant lactate woman , treatment involve unforeseeable risk embryo fetus . 5 . Need chronic maintenance oral steroid . 6 . Active brain metastatic disease . Treated brain metastasis surgery , gammaknife radiosurgery and/or whole brain radiation stable least 4 week steroid eligible . 7 . Any medical psychiatric condition opinion PI would preclude compliance study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Metastatic melanoma</keyword>
	<keyword>anti-OX40</keyword>
	<keyword>Immunostimulatory</keyword>
</DOC>